Comments, Opinions, and Brief Case Reports
October 8, 2001

Anaphylactic Reaction to Ondansetron

Author Affiliations

Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2001

Arch Intern Med. 2001;161(18):2263. doi:

Ondansetron is a selective serotonin receptor (5-HT3) antagonist that is widely used as an antiemetic agent for highly, and now increasingly for moderately, emetogenic chemotherapy.1,2 Although this drug is very well tolerated, the US Food and Drug Administration has received 24 reports of adverse reactions associated with various clinical manifestations of anaphylaxis.3 Another report described 2 cases of anaphylactoid reactions associated with previous ondansetron exposure.4 We report a case of anaphylaxis in a patient with no prior ondansetron exposure.

First Page Preview View Large
First page PDF preview
First page PDF preview